| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.007 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |